What Core Scientific Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 3 | 5 |
| Sells | 15 | 47 |
| Total trades | 24 | 85 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 46,594 | 1,602,396 |
| Disposed | 191,162 | 1,969,485 |
| Net activity | −144,568 | −367,089 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Duchene Todd M | See remarks | Oct 19 | Disclosed 10b5-1 sale · S | −10,000 | $13.87 | −$139K | 1,143,286 |
| Sullivan Adam Taylor | Chief Executive Officer | Oct 16 | Withheld — tax / exercise cost · F | −21,839 | $14.46 | −$316K | 4,391,079 |
| Duchene Todd M | See remarks | Oct 16 | Withheld — tax / exercise cost · F | −6,382 | $14.46 | −$92.3K | 1,153,286 |
| Duchene Todd M | See remarks | Oct 12 | Disclosed 10b5-1 sale · S | −10,000 | $15.12 | −$151K | 1,159,668 |
| Duchene Todd M | See remarks | Oct 05 | Disclosed 10b5-1 sale · S | −10,000 | $16.31 | −$163K | 1,169,668 |
| Sullivan Adam Taylor | Chief Executive Officer | Oct 01 | Withheld — tax / exercise cost · F | −23,508 | $15.98 | −$376K | 4,412,918 |
| Duchene Todd M | See remarks | Oct 01 | Withheld — tax / exercise cost · F | −8,228 | $15.98 | −$131K | 1,179,668 |
| Duchene Todd M | See remarks | Sep 28 | Disclosed 10b5-1 sale · S | −10,000 | $16.76 | −$168K | 1,187,896 |
| Duchene Todd M | See remarks | Sep 21 | Disclosed 10b5-1 sale · S | −10,000 | $18.37 | −$184K | 1,197,896 |
| Weiss Eric Stanton | Director | Sep 15 | Open-market buy · P | +6,000 | $16.33 | +$98K | 265,262 |
| Duchene Todd M | See remarks | Sep 14 | Disclosed 10b5-1 sale · S | −10,000 | $17.14 | −$171K | 1,207,896 |
| Duchene Todd M | See remarks | Sep 08 | Disclosed 10b5-1 sale · S | −10,000 | $18.67 | −$187K | 1,217,896 |
| Duchene Todd M | See remarks | Aug 31 | Disclosed 10b5-1 sale · S | −10,000 | $16.23 | −$162K | 1,927,896 |
| Duchene Todd M | See remarks | Aug 24 | Disclosed 10b5-1 sale · S | −10,000 | $17.45 | −$174K | 1,937,896 |
| Crain Elizabeth | Director | Aug 20 | Open-market buy · P | +6,000 | $18.33 | +$110K | 71,348 |
| Weiss Eric Stanton | Director | Aug 18 | Open-market buy · P | +7,000 | $19.19 | +$134K | 259,262 |
| Duchene Todd M | See remarks | Aug 17 | Withheld — tax / exercise cost · F | −11,205 | $20.13 | −$226K | 1,947,896 |
| Duchene Todd M | See remarks | Aug 17 | Disclosed 10b5-1 sale · S | −10,000 | $20.10 | −$201K | 1,959,101 |
| Duchene Todd M | See remarks | Aug 10 | Disclosed 10b5-1 sale · S | −1,000 | $20.65 | −$20.6K | 1,969,101 |
| Duchene Todd M | See remarks | Aug 10 | Disclosed 10b5-1 sale · S | −9,000 | $19.90 | −$179K | 1,970,101 |
Loading...
